𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan

✍ Scribed by Hideo Tanaka; Tomohiko Hiyama; Hideaki Tsukuma; Yasuto Okubo; Hajime Yamano; Akira Kitada; Isaburo Fujimoto

Publisher
Springer Netherlands
Year
1994
Tongue
English
Weight
431 KB
Volume
5
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of hepatitis C virus RNA preval
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors
✍ Joseph M. Romeo; Paul P. Ulrich; Michael P. Busch; Girish N. Vyas πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 970 KB

Hepatitis C virus (HCV) is the predominant cause of parenterally transmitted non-A, non-B (NANB) hepatitis worldwide (1, 2). Although the clinical manifestations of acute HCV infection are often relatively mild, persistent infection is a frequent outcome and is associated with significant risk of pr

Prevalence of antibodies to hepatitis E
Prevalence of antibodies to hepatitis E virus among Japanese blood donors: Identification of three blood donors infected with a genotype 3 hepatitis E virus
✍ Satoko Fukuda; Junko Sunaga; Nobuo Saito; Kuniko Fujimura; Yaeko Itoh; Masahide πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 2 views

## Abstract Risk factors for acquiring hepatitis E among individuals in industrialized countries including Japan are not fully understood. We investigated whether Japanese blood donors with or without an elevated alanine aminotransferase (ALT) level are likely to have hepatitis E virus (HEV) infect

Prevalence of Amino acid mutation in hep
Prevalence of Amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors
✍ Yasumi Furui; Yuji Hoshi; Kazumoto Murata; Kiyoaki Ito; Kou Suzuki; Shigeharu Uc πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

## Abstract It is not known whether there is a trend of increasing or decreasing incidence of new hepatitis C virus (HCV) infections in Japan. From the treatment point of view, it is important to verify HCV genotypes and the prevalence of treatment‐resistant clones of HCV. At the Japanese Red Cross